Prof. Dr. Carmen Scheibenbogen

Professor of Immunology and physician-researcher

ME/CFS • Post-COVID • autoimmunity • immunodeficiency • off-label drug research

1Episode
33 minAnalysed
1Topic
Last reviewed: Jun 8, 2026·Credential: MD; Professor of Immunology; Deputy Director Institute for Medical Immunology, Charité Berlin; PI on multiple BMBF-funded therapy trials; lead of National Clinical Studies Group ME/CFS + Post-COVID.·First indexed: Jun 8, 2026

About the expert

Focus: Autoimmune mechanisms and therapeutic trials in ME/CFS and Long COVID

Professor of Immunology and Deputy Director of the Institute for Medical Immunology at Charité University Medicine Berlin. Heads the Fatigue Centrum at Charité and leads the National Clinical Studies Group for ME/CFS and Post-COVID Syndrome. Over 15 years of clinical and research focus on autoimmune and infection-driven mechanisms in ME/CFS; over 65 publications including medical guidelines.

Why this matters

Academic clinician-researcher focused on ME/CFS, Long COVID, and the immune mechanisms behind both. Tends to view a meaningful subset of these illnesses as autoantibody-driven, while acknowledging clinical heterogeneity means no single mechanism explains all patients.

Filter by species:

Topics covered